Swiss National Bank Precigen, Inc. Transaction History

Swiss National Bank

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$0.88 - $2.19 $71,544 - $178,047	81,300 Added 33.36%	325,000 $344,000
Q2 2022 Aug 09, 2022	BUY	$1.15 - $2.53 $27,254 - $59,960	23,700 Added 10.77%	243,700 $327,000
Q1 2022 May 09, 2022	BUY	$1.91 - $3.98 $28,077 - $58,506	14,700 Added 7.16%	220,000 $464,000
Q3 2021 Nov 08, 2021	BUY	$4.99 - $6.55 $20,958 - $27,510	4,200 Added 2.09%	205,300 $1.02 Million
Q2 2021 Aug 06, 2021	BUY	$6.24 - $8.22 $197,184 - $259,752	31,600 Added 18.64%	201,100 $1.31 Million
Q1 2021 May 07, 2021	BUY	$6.74 - $10.95 $97,730 - $158,775	14,500 Added 9.35%	169,500 $1.17 Million
Q3 2020 Nov 09, 2020	BUY	$3.5 - $6.2 $34,650 - $61,380	9,900 Added 6.82%	155,000 $543,000
Q2 2020 Aug 05, 2020	BUY	$2.16 - $5.46 $11,664 - $29,484	5,400 Added 3.87%	145,100 $724,000
Q1 2020 May 08, 2020	BUY	$1.46 - $7.19 $203,962 - $1 Million	139,700 New	139,700 $475,000

140

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $281M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.